Zhuhai Livzon Diagnostics Inc. (“LivzonDx”) was established in 1989 and is the first subsidiary of Livzon Pharmaceutical Group, a publicly listed company. As a National High-Tech Enterprise, we are among the pioneers in China’s in vitro diagnostics (IVD) industry.

At LivzonDx, we specialize in the R&D, manufacturing, sales and marketing of IVD products. Our products are widely used in over 5,000 medical institutions worldwide, particularly in the fields of infectious diseases, autoimmune diseases, and blood safety.

We have established a comprehensive multi-technology platform, including PCR-based molecular diagnostics, multiplex liquid-phase chip technology, chemiluminescence immunoassay (CLIA), point-of-care testing (POCT), enzyme-linked immunosorbent assay (ELISA), particle agglutination, and raw material development. Leveraging our capabilities in both reagent and automated instrument development, we deliver integrated and scalable solutions tailored to diverse clinical needs.